English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52667484    ???header.onlineuser??? :  735
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

???jsp.browse.items-by-title.jump??? [ ???jsp.browse.general.jump2chinese??? ] [ ???jsp.browse.general.jump2numbers??? ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
???jsp.browse.items-by-title.enter???   

Showing items 273611-273620 of 2348617  (234862 Page(s) Totally)
<< < 27357 27358 27359 27360 27361 27362 27363 27364 27365 27366 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-04-10T12:16:09Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer YU-YUN SHAO; Shau W.-Y.; Lin Z.-Z.; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-05-26T09:27:04Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer Shao Y.-Y;Shau W.-Y;Lin Z.-Z;Chen H.-M;Kuo R;Chih-Hsin Yang;Lai M.-S.; Shao Y.-Y; Shau W.-Y; Lin Z.-Z; Chen H.-M; Kuo R; CHIH-HSIN YANG; Lai M.-S.
臺大學術典藏 2021-08-11T03:46:44Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2022-06-10T06:11:07Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2018-09-10T08:29:55Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu, J.-Y. and Wu, S.-G. and Yang, C.-H. and Chang, Y.-L. and Chang, Y.-C. and Hsu, Y.-C. and Shih, J.-Y. and Yang, P.-C.; YIH-LEONG CHANG; YEUN-CHUNG CHANG; JIN-YUAN SHIH
臺大學術典藏 2020-05-26T09:27:13Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C.
臺大學術典藏 2011 Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Yang P.-C.; Shih J.-Y.; Hsu Y.-C.; Chang Y.-C.; Chang Y.-L.; Yang C.-H.; SHANG-GIN WU; Wu J.-Y.
臺大學術典藏 2020-08-13T06:33:53Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2011 Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Yang C.-H.; YIH-LEONG CHANG; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.; Wu S.-G.; Wu J.-Y.
臺大學術典藏 2020-03-07T06:56:38Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y. ;Wu S.-G. ;Yang C.-H. ;Yih-Leong Chang ;Chang Y.-C. ;Hsu Y.-C. ;Shih J.-Y. ;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; YIH-LEONG CHANG; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.

Showing items 273611-273620 of 2348617  (234862 Page(s) Totally)
<< < 27357 27358 27359 27360 27361 27362 27363 27364 27365 27366 > >>
View [10|25|50] records per page